Can we predict who will benefit from liver cancer immunotherapy?
NCT ID NCT06796114
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 27 times
Summary
This study aims to identify biological markers (biomarkers) that can predict outcomes in people with advanced liver cancer treated with the immunotherapy drugs tremelimumab and durvalumab. Researchers will follow 120 participants who have not had prior systemic treatment and are eligible for this therapy in routine care. The goal is to better understand which patients are most likely to benefit, improving personalized treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CH de Chalon sur Saône
RECRUITINGChalon-sur-Saône, France
Contact
-
CH de Mulhouse
RECRUITINGMulhouse, France
Contact
-
CHU Grenoble
RECRUITINGGrenoble, France
Contact
-
CHU Poitiers
NOT_YET_RECRUITINGPoitiers, France
Contact
-
CHU de Besançon
RECRUITINGBesançon, France
Contact
-
CHU de Reims
NOT_YET_RECRUITINGReims, France
Contact
-
Hôpital Beaujon - APHP
RECRUITINGParis, France
Contact
-
Hôpital Henri Mondor - APHP
NOT_YET_RECRUITINGParis, France
Contact
-
Hôpital La Pitié Salpêtrière - APHP
RECRUITINGParis, France
Contact
-
ICANS
NOT_YET_RECRUITINGStrasbourg, France
Contact
Conditions
Explore the condition pages connected to this study.